Part III: The Citric Acid Cycle & Oxidative Phosphorylation
The mitochondrion is the powerhouse of the cell. In this part we follow the carbon atoms of acetyl-CoA through the citric acid cycle, trace the electrons harvested by NADH and FADH₂ down the electron transport chain, and witness the elegant rotary mechanism of ATP synthase as it converts the proton-motive force into the universal energy currency of life.
Energy Harvest at a Glance
30–32
ATP per Glucose
10 H⁺
Pumped per NADH
~34%
Thermodynamic Efficiency
120° per ATP
ATP Synthase Rotation
1. The Citric Acid Cycle (Krebs Cycle)
Discovery and Significance
The citric acid cycle — also known as the tricarboxylic acid (TCA) cycle or the Krebs cycle — was elucidated by the German-British biochemist Hans Krebs in 1937. For this monumental contribution to our understanding of intermediary metabolism, Krebs was awarded the Nobel Prize in Physiology or Medicine in 1953. The cycle represents the central metabolic hub of the cell, the common pathway for the oxidation of fuel molecules — carbohydrates, fatty acids, and amino acids — and it provides the reducing equivalents that drive oxidative phosphorylation.
The TCA cycle takes place entirely within the mitochondrial matrix. Acetyl-CoA, produced by the pyruvate dehydrogenase complex (from carbohydrate metabolism) or by β-oxidation (from fatty acid metabolism), enters the cycle by condensing with the four-carbon acceptor oxaloacetate (OAA) to form the six-carbon molecule citrate. Through a series of eight enzymatic steps, the two carbon atoms entering as acetyl-CoA are ultimately released as CO₂, while the energy liberated is captured in the reduced coenzymes NADH and FADH₂, plus one molecule of GTP (or ATP) via substrate-level phosphorylation. The oxaloacetate is regenerated, allowing the cycle to turn continuously.
The Eight Steps in Detail
Each reaction of the cycle is catalyzed by a specific enzyme. Below we examine every step, noting the substrates, products, type of reaction, and thermodynamic significance.
Step 1: Citrate Synthase
Reaction: Acetyl-CoA + Oxaloacetate + H₂O → Citrate + CoA-SH
This is an aldol condensation followed by hydrolysis of the thioester bond. The cleavage of the energy-rich thioester bond of acetyl-CoA drives the reaction strongly in the forward direction. Citrate synthase is a dimeric enzyme that undergoes a large conformational change upon binding oxaloacetate, creating the binding site for acetyl-CoA — an example of induced fit.
\(\Delta G^{\circ\prime} = -31.4 \text{ kJ/mol}\) — essentially irreversible under physiological conditions.
Step 2: Aconitase
Reaction: Citrate ↔ Isocitrate (via cis-Aconitate)
Aconitase catalyzes a near-equilibrium isomerization through a dehydration/rehydration mechanism. Citrate is first dehydrated to the enzyme-bound intermediate cis-aconitate, which is then rehydrated to isocitrate. The enzyme contains an iron-sulfur cluster [4Fe-4S] that participates directly in the binding and dehydration of citrate. Importantly, the rearrangement converts a tertiary alcohol (citrate) to a secondary alcohol (isocitrate), which can be oxidized in the next step.
\(\Delta G^{\circ\prime} = +6.3 \text{ kJ/mol}\) — pulled forward by rapid removal of isocitrate.
Step 3: Isocitrate Dehydrogenase
Reaction: Isocitrate + NAD⁺ → α-Ketoglutarate + CO₂ + NADH
This is the first oxidative decarboxylation of the cycle — the first point at which a carbon atom is released as CO₂ and a molecule of NADH is generated. Isocitrate dehydrogenase catalyzes an oxidation of the secondary alcohol to a ketone (oxalosuccinate), followed immediately by decarboxylation to yield α-ketoglutarate. The mitochondrial enzyme uses NAD⁺ as the electron acceptor and is one of the key regulatory enzymes of the cycle. It is allosterically activated by ADP and Ca²⁺ and inhibited by ATP and NADH.
\(\Delta G^{\circ\prime} = -20.9 \text{ kJ/mol}\) — a major regulatory step.
Step 4: α-Ketoglutarate Dehydrogenase Complex
Reaction: α-Ketoglutarate + NAD⁺ + CoA-SH → Succinyl-CoA + CO₂ + NADH
This is the second oxidative decarboxylation of the cycle. The α-ketoglutarate dehydrogenase complex is structurally and mechanistically analogous to the pyruvate dehydrogenase complex, employing the same five coenzymes: thiamine pyrophosphate (TPP), lipoamide, CoA-SH, FAD, and NAD⁺. The reaction is essentially irreversible and produces the energy-rich thioester succinyl-CoA. Like pyruvate dehydrogenase, the complex consists of three enzyme components: E1 (α-ketoglutarate dehydrogenase), E2 (dihydrolipoyl succinyltransferase), and E3 (dihydrolipoyl dehydrogenase).
\(\Delta G^{\circ\prime} = -33.5 \text{ kJ/mol}\) — irreversible, major control point.
Step 5: Succinyl-CoA Synthetase
Reaction: Succinyl-CoA + GDP + Pᵢ ↔ Succinate + CoA-SH + GTP
This is the only substrate-level phosphorylation in the citric acid cycle. The energy released by hydrolysis of the thioester bond of succinyl-CoA is conserved in the formation of a phosphoanhydride bond in GTP (in animal cells) or ATP (in plants and some bacteria). The GTP produced is energetically equivalent to ATP and can be converted to ATP by nucleoside diphosphate kinase: GTP + ADP ↔ GDP + ATP. The reaction proceeds through a succinyl-phosphate intermediate and involves a phosphohistidine residue on the enzyme.
\(\Delta G^{\circ\prime} = -2.9 \text{ kJ/mol}\) — near equilibrium.
Step 6: Succinate Dehydrogenase (Complex II)
Reaction: Succinate + FAD → Fumarate + FADH₂
Succinate dehydrogenase is unique among TCA cycle enzymes in two respects: it is the only enzyme embedded in the inner mitochondrial membrane (all others are soluble in the matrix), and it is simultaneously Complex II of the electron transport chain. The enzyme uses FAD rather than NAD⁺ as electron acceptor because the free energy change of succinate oxidation is insufficient to reduce NAD⁺. The FAD is covalently bound to a histidine residue of the enzyme. The electrons from FADH₂ are passed through iron-sulfur clusters to ubiquinone (CoQ) in the membrane.
\(\Delta G^{\circ\prime} = 0 \text{ kJ/mol}\) — near equilibrium; FAD is required because \(\Delta E^{\circ\prime}\) is too small for NAD⁺.
Step 7: Fumarase
Reaction: Fumarate + H₂O ↔ L-Malate
Fumarase (fumarate hydratase) catalyzes the stereospecific trans-addition of water across the double bond of fumarate to produce L-malate. The enzyme is highly stereospecific, producing exclusively the L-isomer of malate. This is a simple hydration reaction with a free energy change close to zero.
\(\Delta G^{\circ\prime} = -3.8 \text{ kJ/mol}\)
Step 8: Malate Dehydrogenase
Reaction: L-Malate + NAD⁺ ↔ Oxaloacetate + NADH + H⁺
The final step of the cycle regenerates oxaloacetate, completing the catalytic cycle. Although the standard free energy change is highly unfavorable (strongly endergonic), the reaction is pulled forward under physiological conditions because the concentration of oxaloacetate in the mitochondrial matrix is kept extremely low — it is immediately consumed by citrate synthase in step 1. The coupling of steps 8 and 1 ensures continuous cycling.
\(\Delta G^{\circ\prime} = +29.7 \text{ kJ/mol}\) — thermodynamically unfavorable but pulled forward by low [OAA].
Net Equation per Turn of the Cycle
Overall Reaction:
Products per Acetyl-CoA
- • 3 NADH (steps 3, 4, 8)
- • 1 FADH₂ (step 6)
- • 1 GTP (step 5)
- • 2 CO₂ (steps 3, 4)
Per Glucose (2 turns)
- • 6 NADH
- • 2 FADH₂
- • 2 GTP
- • 4 CO₂
Amphibolic Nature of the TCA Cycle
The citric acid cycle is not solely catabolic — it is amphibolic, serving both catabolic and anabolic roles. Several TCA cycle intermediates are drawn off as biosynthetic precursors:
Biosynthetic Drain
- • Citrate → fatty acid synthesis (exported to cytosol)
- • α-Ketoglutarate → amino acid synthesis (glutamate family)
- • Succinyl-CoA → heme biosynthesis (porphyrin ring)
- • Oxaloacetate → gluconeogenesis (via PEP), aspartate family amino acids
Anaplerotic Reactions
To replenish intermediates withdrawn for biosynthesis, anaplerotic (“filling up”) reactions feed new carbon skeletons into the cycle:
- • Pyruvate carboxylase: Pyruvate + CO₂ + ATP → OAA (most important in mammals)
- • Glutamate dehydrogenase: Glutamate → α-Ketoglutarate + NH₄⁺
- • PEP carboxykinase (reverse): PEP + CO₂ → OAA
- • Transamination: Aspartate → OAA
Key Anaplerotic Reaction — Pyruvate Carboxylase:
Activated by acetyl-CoA (allosteric activator) — when acetyl-CoA accumulates, more OAA is made to allow cycle entry.
2. TCA Cycle Regulation
Principles of Regulation
The rate of the citric acid cycle is precisely matched to the cell’s demand for ATP. When the cell has abundant energy (high [ATP], high [NADH]), the cycle slows; when energy is depleted (high [ADP], low [NADH]), it accelerates. Regulation occurs primarily at three irreversible steps catalyzed by enzymes with large negative free energy changes: citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase.
The central concept is energy charge regulation. The ratio of [ATP] to [ADP] and the ratio of [NADH] to [NAD⁺] serve as the primary signals communicating the cell’s energy status to the TCA cycle enzymes. A high energy charge (high ATP/ADP and NADH/NAD⁺) signals that the cell has sufficient energy, and the cycle slows accordingly.
The Three Regulated Enzymes
1. Citrate Synthase
Inhibitors (slow the cycle):
- • ATP — competitive inhibitor with respect to OAA
- • NADH — signals high energy charge
- • Succinyl-CoA — product of later step (competitive with acetyl-CoA)
- • Citrate — product inhibition
- • Long-chain fatty acyl-CoA — alternative fuel signal
Activators (speed up the cycle):
- • ADP — signals low energy charge
- • Substrate availability (acetyl-CoA, OAA)
The reaction is controlled primarily by substrate availability — particularly the concentration of OAA, which is normally very low in the matrix.
2. Isocitrate Dehydrogenase (NAD⁺-dependent)
Inhibitors:
- • ATP — allosteric inhibitor
- • NADH — product inhibition, signals energy sufficiency
Activators:
- • ADP — allosteric activator, signals energy depletion
- • Ca²⁺ — lowers Kᵐ for isocitrate, critical during muscle contraction
Isocitrate DH is often considered the primary rate-determining enzyme of the cycle because the isocitrate/α-ketoglutarate step commits carbon to continued oxidation.
3. α-Ketoglutarate Dehydrogenase Complex
Inhibitors:
- • Succinyl-CoA — product inhibition
- • NADH — product inhibition, energy signal
- • ATP — energy charge signal (indirect)
Activators:
- • Ca²⁺ — lowers Kᵐ for α-ketoglutarate
- • AMP — signals severe energy depletion
Unlike pyruvate dehydrogenase, the α-KG dehydrogenase complex is not regulated by covalent modification (phosphorylation) in mammals.
Calcium Signaling and Muscle Contraction
Calcium ions play a critical role in coordinating energy production with energy demand, particularly in muscle. During muscle contraction, Ca²⁺ is released from the sarcoplasmic reticulum into the cytoplasm and is taken up by mitochondria. Within the mitochondrial matrix, Ca²⁺ simultaneously activates three key enzymes:
- • Pyruvate dehydrogenase — activated by Ca²⁺-stimulated phosphatase (dephosphorylation activates PDH)
- • Isocitrate dehydrogenase — Ca²⁺ lowers the Kᵐ for isocitrate by ~10-fold
- • α-Ketoglutarate dehydrogenase — Ca²⁺ lowers the Kᵐ for α-KG
This ensures that when a muscle is actively contracting and consuming ATP, the TCA cycle and oxidative phosphorylation are simultaneously stimulated to replenish the ATP supply. The same Ca²⁺ signal that initiates contraction also accelerates the metabolic pathways that provide the fuel.
Summary of Flux Determinants
| Factor | Effect on TCA Cycle | Mechanism |
|---|---|---|
| High [ATP]/[ADP] | Inhibits | ATP inhibits CS, IDH; ADP activates IDH |
| High [NADH]/[NAD⁺] | Inhibits | NADH inhibits all three regulated enzymes |
| High [Ca²⁺] | Activates | Activates IDH, α-KG DH, and PDH phosphatase |
| [Acetyl-CoA] supply | Activates | Substrate availability for citrate synthase |
| [OAA] availability | Activates | Substrate for citrate synthase; maintained by anaplerosis |
| High [Succinyl-CoA] | Inhibits | Product inhibition of α-KG DH and CS |
3. The Electron Transport Chain
Overview: From Reducing Equivalents to Proton Gradient
The electron transport chain (ETC) — also called the respiratory chain — is the final common pathway for the oxidation of NADH and FADH₂. Located in the inner mitochondrial membrane, it consists of four large multi-subunit protein complexes (I–IV) plus two mobile electron carriers (coenzyme Q and cytochrome c). As electrons flow from donors of high reducing potential (NADH, FADH₂) to the terminal acceptor oxygen, the free energy released is used to pump protons from the matrix to the intermembrane space, creating an electrochemical gradient that drives ATP synthesis.
Fundamental Thermodynamic Relationship:
where n = number of electrons transferred, F = Faraday constant (96,485 J/V·mol), and \(\Delta E^{\circ\prime}\) = difference in standard reduction potentials.
The overall reaction of the electron transport chain is the oxidation of NADH by molecular oxygen:
Complex I: NADH:Ubiquinone Oxidoreductase
Complex I is the largest complex of the respiratory chain, with a molecular mass of approximately 980 kDa in mammals and containing 45 subunits (14 of which are core catalytic subunits conserved from bacteria). It has an L-shaped structure, with a hydrophilic arm protruding into the matrix (where NADH binds) and a hydrophobic arm embedded in the membrane (where proton pumping occurs).
Electron Transfer Pathway in Complex I
NADH → FMN → [N1a] → [N3] → [N1b] → [N4] → [N5] → [N6a] → [N6b] → [N2] → CoQ
- • FMN (flavin mononucleotide): Accepts 2 electrons from NADH as a hydride
- • Fe-S clusters (N1a through N2): A chain of 8 iron-sulfur clusters spanning ~95 Å provides a “wire” for single-electron transfer
- • Coenzyme Q (ubiquinone): Terminal electron acceptor; reduced to ubiquinol (CoQH₂)
Protons Pumped:
4 H⁺ per NADH oxidized
Reduction Potentials:
\(\Delta E^{\circ\prime} = +0.36 \text{ V}\) (NADH → CoQ)
Complex II: Succinate Dehydrogenase
Complex II is the simplest of the respiratory chain complexes, consisting of only four subunits. It is unique in that it participates in both the TCA cycle (as succinate dehydrogenase, step 6) and the electron transport chain. Electrons from succinate oxidation pass through the covalently-bound FAD cofactor and three iron-sulfur clusters before reducing ubiquinone to ubiquinol.
Key Features of Complex II
Succinate → FAD → [2Fe-2S] → [4Fe-4S] → [3Fe-4S] → CoQ
- • No proton pumping: The free energy change (\(\Delta E^{\circ\prime} = +0.03 \text{ V}\)) is too small to drive proton translocation
- • Electrons from FADH₂ enter at a lower energy level than those from NADH
- • Contains a heme b that does not participate in electron transfer but may prevent ROS formation
- • FADH₂ from other flavoprotein dehydrogenases (e.g., acyl-CoA dehydrogenase via ETF-QO) also feed electrons to CoQ
Coenzyme Q (Ubiquinone): The Mobile Carrier
Coenzyme Q (CoQ, also called ubiquinone) is a small, hydrophobic molecule that diffuses freely within the lipid bilayer of the inner mitochondrial membrane. It serves as a mobile electron shuttle, collecting electrons from Complexes I and II (and other dehydrogenases) and delivering them to Complex III. CoQ can exist in three redox states: fully oxidized (ubiquinone, Q), partially reduced (semiquinone radical, QH•), and fully reduced (ubiquinol, QH₂). The two-electron, two-proton reduction allows CoQ to serve as both an electron and proton carrier. The isoprenoid tail (typically 10 isoprene units in humans, hence CoQ₁₀) anchors it within the hydrophobic membrane interior.
Complex III: Cytochrome bc₁ Complex
Complex III (also called ubiquinol:cytochrome c oxidoreductase or the cytochrome bc₁ complex) transfers electrons from ubiquinol (CoQH₂) to the soluble protein cytochrome c. The complex functions as a dimer, with each monomer containing 11 subunits. The key prosthetic groups are cytochrome b (with two heme groups, bᴘ and bᴴ), cytochrome c₁ (with one heme), and the Rieske iron-sulfur protein [2Fe-2S].
The Q Cycle Mechanism
The Q cycle, proposed by Peter Mitchell, explains how Complex III couples electron transfer to proton translocation with a 4 H⁺/2e⁻ stoichiometry. The cycle requires two molecules of QH₂ to be oxidized for every one molecule of Q to be reduced:
First Half-Cycle:
- • QH₂ binds at Qᵖ site (near IMS)
- • One e⁻ → Rieske FeS → cyt c₁ → cyt c (high-potential path)
- • Other e⁻ → cyt bᴘ → cyt bᴴ → Q at Qᵢ site (low-potential path)
- • 2 H⁺ released to IMS from QH₂
- • Q at Qᵢ becomes semiquinone (Q•⁻)
Second Half-Cycle:
- • Second QH₂ binds at Qᵖ site
- • One e⁻ → cyt c (via high-potential path) — second cyt c reduced
- • Other e⁻ → Qᵢ semiquinone, completing reduction to QH₂
- • 2 H⁺ released to IMS
- • 2 H⁺ taken from matrix to reduce Q⁻ to QH₂
Net per pair of electrons reaching cyt c:
4 H⁺ translocated (2 released to IMS from QH₂ + 2 consumed from matrix to regenerate QH₂) and 2 cytochrome c molecules reduced.
Cytochrome c: The Second Mobile Carrier
Cytochrome c is a small (~12.4 kDa), soluble, single-electron carrier that shuttles electrons from Complex III to Complex IV along the outer face of the inner mitochondrial membrane in the intermembrane space (IMS). It contains a single heme c group covalently attached via thioether bonds to two cysteine residues. Cytochrome c is one of the most highly conserved proteins in evolution, reflecting its essential role in aerobic respiration. Notably, the release of cytochrome c from mitochondria into the cytoplasm is a key trigger for apoptosis (programmed cell death), activating the caspase cascade via the apoptosome.
Complex IV: Cytochrome c Oxidase
Complex IV (cytochrome c oxidase) is the terminal enzyme of the respiratory chain, catalyzing the four-electron reduction of molecular oxygen to water. In mammals, it consists of 13 subunits, with the three largest (subunits I, II, and III) encoded by mitochondrial DNA. The enzyme contains four redox-active metal centers: Cuᴀ (a binuclear copper center in subunit II), heme a (in subunit I), and the binuclear heme a₃–Cuᴁ center (in subunit I) where oxygen binds and is reduced.
Electron Transfer and O₂ Reduction
cyt c → Cuᴀ → heme a → [heme a₃–Cuᴁ] → O₂
The overall reaction at Complex IV:
Protons Pumped:
2 H⁺ per pair of electrons (4 H⁺ per O₂). Additionally, 4 “chemical” protons are consumed from the matrix to make 2 H₂O.
Reduction Potential:
\(\Delta E^{\circ\prime} = +0.56 \text{ V}\) (cyt c → O₂);\(\Delta G^{\circ\prime} = -108 \text{ kJ/mol}\) per pair of electrons
Total Proton Translocation
| Complex | Electron Source | H⁺ Pumped (per 2e⁻) | \(\Delta E^{\circ\prime}\) (V) |
|---|---|---|---|
| Complex I | NADH → CoQ | 4 | +0.36 |
| Complex II | FADH₂ → CoQ | 0 | +0.03 |
| Complex III | CoQH₂ → cyt c | 4 | +0.19 |
| Complex IV | cyt c → O₂ | 2 | +0.56 |
| Total per NADH (I → III → IV): | 10 | +1.14 | |
| Total per FADH₂ (II → III → IV): | 6 | +0.78 | |
ETC Inhibitors
The respiratory chain can be blocked at specific sites by various inhibitors, which have been invaluable tools for elucidating the order of electron carriers. Block at any complex stops electron flow and proton pumping, halting ATP synthesis and potentially causing cell death.
Complex I Inhibitors
- • Rotenone — plant-derived insecticide/piscicide
- • Piericidin A — structural analog of CoQ
- • Barbiturates (e.g., amobarbital)
Block electron transfer from Fe-S cluster N2 to CoQ
Complex III Inhibitors
- • Antimycin A — blocks Qᵢ site (from Streptomyces)
- • Myxothiazol — blocks Qᵖ site
Antimycin A is a classic Q cycle inhibitor
Complex IV Inhibitors
- • Cyanide (CN⁻) — binds Fe³⁺ of heme a₃
- • Carbon monoxide (CO) — binds Fe²⁺ of heme a₃
- • Hydrogen sulfide (H₂S)
- • Azide (N₃⁻)
Block oxygen binding at the binuclear center
4. Chemiosmotic Coupling (Mitchell’s Hypothesis)
A Revolutionary Proposal
In 1961, the British biochemist Peter Mitchell proposed the chemiosmotic hypothesis — the idea that the energy of electron transport is conserved not in a “high-energy chemical intermediate” (as most biochemists assumed at the time) but in an electrochemical proton gradient across the inner mitochondrial membrane. This gradient, called the proton-motive force (pmf or Δp), drives ATP synthesis by ATP synthase.
Mitchell’s hypothesis was initially met with fierce resistance, but a wealth of experimental evidence accumulated in its favor over the next two decades. Mitchell was awarded the Nobel Prize in Chemistry in 1978 for this transformative insight, which unified the understanding of energy transduction in mitochondria, chloroplasts, and bacteria.
The Proton-Motive Force
The proton-motive force has two components: the membrane potential (Δψ, the charge difference across the membrane) and the pH gradient (ΔpH, the concentration difference of H⁺ ions). The total pmf is given by:
Proton-Motive Force Equation:
At 37 °C (310 K): \(\frac{2.303\,RT}{F} = \frac{2.303 \times 8.314 \times 310}{96{,}485} \approx 61.5 \text{ mV}\)
Convention: Δψ is positive (matrix negative relative to IMS); ΔpH = pHᵢᵗ − pHᵉᵤᵗ is negative (matrix more alkaline).
Magnitude of the Proton-Motive Force
Typical Values in Mitochondria
Δψ ≈ 150–180 mV
Membrane potential (dominant component)
ΔpH ≈ 0.5–1.0
pH units (matrix more alkaline)
Δp ≈ 200–220 mV
Total proton-motive force
In mitochondria, the membrane potential (Δψ) contributes roughly 75–80% of the total pmf, with the pH gradient contributing the remaining 20–25%. This differs from chloroplasts, where ΔpH is dominant.
Experimental Evidence for Chemiosmosis
Several key experiments established the chemiosmotic hypothesis beyond doubt:
- • Jagendorf’s acid-bath experiment (1966): Chloroplast thylakoids incubated at pH 4 (to load the interior with H⁺), then transferred to pH 8 buffer in the dark, synthesized ATP. This demonstrated that an artificially imposed ΔpH alone was sufficient to drive ATP synthesis, without any electron transport.
- • Reconstitution experiments (Racker & Stoeckenius, 1974): Purified bacteriorhodopsin (a light-driven proton pump) and purified bovine ATP synthase were reconstituted together into artificial lipid vesicles. Upon illumination, the system pumped protons and synthesized ATP, demonstrating that only a proton gradient and ATP synthase are needed — no specific electron transport complex is required.
- • Protonophore uncoupling: The observation that lipophilic weak acids like DNP dissipate the proton gradient and abolish ATP synthesis while stimulating electron transport provided strong evidence that the gradient (not a chemical intermediate) couples respiration to phosphorylation.
- • Inner membrane impermeability: The finding that the inner mitochondrial membrane is essentially impermeable to protons (except through specific channels) was critical — without this barrier, a stable gradient could not be maintained.
Free Energy Available per Proton:
With ~4 H⁺ required per ATP, the total free energy available is ~77 kJ/mol, comfortably exceeding the \(\Delta G\) for ATP synthesis under cellular conditions (~50–54 kJ/mol).
Uncouplers of Oxidative Phosphorylation
Uncouplers are lipophilic weak acids that can carry protons across the inner mitochondrial membrane, short-circuiting the proton gradient. When an uncoupler is present, electron transport continues (even accelerates, since the gradient is dissipated), but ATP synthesis ceases. The energy of the gradient is instead released as heat.
Chemical Uncouplers
- • 2,4-Dinitrophenol (2,4-DNP): The classic uncoupler, historically used (dangerously) as a weight-loss drug in the 1930s. Its protonated form is lipophilic and carries H⁺ across the membrane; the deprotonated form diffuses back.
- • FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone): A potent synthetic uncoupler widely used in research. More effective than DNP and commonly used to measure maximal respiratory capacity.
Biological Uncoupling: Thermogenin (UCP1)
Uncoupling protein 1 (UCP1), also called thermogenin, is a proton channel found in the inner mitochondrial membrane of brown adipose tissue (BAT). It allows protons to flow back into the matrix without passing through ATP synthase, dissipating the gradient as heat.
- • Essential for non-shivering thermogenesis in neonates and hibernating animals
- • Brown fat is rich in mitochondria (hence the color from cytochromes)
- • Activated by free fatty acids, inhibited by purine nucleotides (GDP, ATP)
- • Adult humans retain functional brown fat depots (cervical, supraclavicular)
- • UCP2 and UCP3 exist in other tissues but have different (debated) functions
5. ATP Synthase (Complex V)
Structure of the Molecular Machine
ATP synthase (F₁F₀-ATPase, also called Complex V) is one of the most remarkable molecular machines in biology. It converts the energy stored in the proton-motive force into the chemical energy of ATP through a rotary catalytic mechanism. The enzyme consists of two major functional domains:
F₀ Domain (Membrane Sector)
- • c-ring: A ring of c-subunits (typically 8–15 depending on species; ~10 in mammals) embedded in the inner membrane. Each c-subunit has a proton-binding site (conserved Asp or Glu residue)
- • a-subunit: Contains two half-channels for proton entry and exit, positioned adjacent to the c-ring
- • b-subunit (peripheral stalk): Connects F₀ to F₁, serving as the stator to prevent co-rotation
F₁ Domain (Catalytic Sector)
- • α₃β₃ hexamer: Alternating α and β subunits forming a spherical crown. The three β subunits contain the catalytic sites for ATP synthesis
- • γ-subunit (central rotor shaft): An asymmetric coiled-coil that extends from the c-ring through the center of the α₃β₃ hexamer. Its rotation drives conformational changes in the β subunits
- • δ and ε subunits: Connect the γ-subunit to the c-ring (rotor assembly)
Boyer’s Binding Change Mechanism
Paul Boyer proposed the binding change mechanism in 1973 and refined it over subsequent decades, sharing the Nobel Prize in Chemistry in 1997 with John Walker (who determined the crystal structure of F₁). The key insight is that the energy of the proton gradient is not used directly to form the phosphoanhydride bond of ATP, but rather to release tightly bound ATP from the catalytic site. The chemistry of ATP synthesis occurs spontaneously at the active site — the binding energy alone drives the reaction.
The Three-State Rotary Cycle
The three β subunits exist in three distinct conformational states at any instant, cycling through them as the γ-subunit rotates:
O (Open)
Low affinity for substrates and products. ADP + Pᵢ can bind; ATP is released. The open conformation is the state that allows substrate entry and product departure.
L (Loose)
ADP and Pᵢ are loosely bound. The substrates are oriented but catalysis has not yet occurred. The site is not catalytically competent in this state.
T (Tight)
Substrates are tightly bound and ATP synthesis occurs spontaneously. The binding energy stabilizes the transition state. ATP is trapped in the closed active site.
One Complete Revolution (360°):
Each 120° rotation of the γ-subunit advances each β subunit to the next state: O → L → T → O. Since there are three β subunits, one full rotation (360°) produces 3 ATP molecules. The rotation has been directly visualized in the landmark experiment by Noji et al. (1997), who attached a fluorescent actin filament to the γ-subunit and observed discrete 120° steps under a microscope.
Proton Stoichiometry
The number of protons required per ATP depends on the number of c-subunits in the c-ring, since one full rotation of the ring requires one proton per c-subunit and produces 3 ATP:
With approximately 10 c-subunits in mammalian ATP synthase:
Including the cost of transporting ATP out and ADP/Pᵢ into the matrix (1 additional H⁺ for the ATP-ADP translocase), the effective cost is approximately 4 H⁺ per ATP delivered to the cytoplasm.
Mitochondrial Transport Systems
ATP-ADP Translocase (ANT)
Also called adenine nucleotide translocator. This antiporter exports one ATP⁴⁻ from the matrix while importing one ADP³⁻ from the IMS. Since ATP carries one more negative charge than ADP, the exchange is driven by the membrane potential (Δψ, matrix negative) — the electrogenic transport effectively costs ~1 H⁺ equivalent.
Inhibitors: Atractyloside (blocks from outside), bongkrekic acid (blocks from matrix side).
Phosphate Carrier
Imports inorganic phosphate (Pᵢ) into the matrix in symport with one H⁺. This electroneutral transport (H₂PO₄⁻ + H⁺ exchange for OH⁻) is driven by the ΔpH component of the proton-motive force.
The combined cost of ATP export (via ANT) and Pᵢ import adds approximately 1 H⁺ to the cost of each ATP synthesized, bringing the total to ~4 H⁺/ATP.
How Proton Flow Drives Rotation
The a-subunit of F₀ contains two offset half-channels that do not span the full membrane. Protons from the IMS enter through the upper half-channel, bind to a conserved carboxylate residue (Asp61 in E. coli) on a c-subunit, and the c-ring rotates to bring the protonated site past the hydrophobic barrier of the membrane. When the protonated c-subunit reaches the lower half-channel, the proton is released into the matrix. Because an essential arginine residue on the a-subunit electrostatically prevents passage of protonated c-subunits, the ring can only rotate in one direction. The torque generated by this Brownian ratchet mechanism is substantial — approximately 40–50 pN·nm, making ATP synthase one of the most efficient molecular motors known, approaching nearly 100% thermodynamic efficiency in converting the pmf into mechanical rotation and then into chemical bond energy.
ATP Synthase by the Numbers
~130
Revolutions per second
~390
ATP molecules per second
~600 kDa
Total molecular mass
~10 nm
Diameter of F₁ head
Regulation: The IF₁ Inhibitory Factor
Under conditions of hypoxia or ischemia, when the electron transport chain stops and the proton gradient collapses, ATP synthase can run in reverse — hydrolyzing ATP to pump protons and maintain Δψ. This wasteful consumption of ATP is prevented by inhibitory factor 1 (IF₁), a small protein that binds to the catalytic interface of F₁ and blocks ATP hydrolysis specifically. IF₁ is active at low pH (as occurs during ischemia when lactate accumulates) and exists as an inactive dimer at normal matrix pH (~7.8). This elegant mechanism protects the cell’s ATP reserves during metabolic stress.
6. Complete Glucose Oxidation — The ATP Balance Sheet
Tallying the Energy Harvest
We can now trace the complete oxidation of one molecule of glucose to CO₂ and H₂O and calculate the total ATP yield. The pathway involves glycolysis (cytoplasm), pyruvate dehydrogenase (mitochondrial matrix), the TCA cycle (matrix), and oxidative phosphorylation (inner membrane). The total depends on which NADH shuttle system operates in the tissue (since cytoplasmic NADH cannot directly cross the inner mitochondrial membrane).
| Stage | NADH | FADH₂ | ATP/GTP (SLP) | ATP via OxPhos |
|---|---|---|---|---|
| Glycolysis | 2 | — | 2 ATP | 3 or 5* |
| 2 × Pyruvate Dehydrogenase | 2 | — | — | 5 |
| 2 × TCA Cycle | 6 | 2 | 2 GTP | 15 + 3 = 18 |
| Totals | 10 | 2 | 4 | 26 or 28 |
| Grand Total ATP: | 30 or 32 | |||
* The yield from glycolytic NADH depends on the shuttle used (see below). P/O ratios used: NADH ≈ 2.5, FADH₂ ≈ 1.5.
P/O Ratios
The P/O ratio is the number of ATP molecules synthesized per atom of oxygen consumed (per pair of electrons reaching O₂). Modern consensus values, based on the non-integer H⁺/ATP stoichiometry (~4 H⁺/ATP including transport costs), are:
P/O ≈ 2.5
NADH: 10 H⁺ pumped ÷ 4 H⁺/ATP = 2.5 ATP per NADH
\(\frac{10 \text{ H}^+}{4 \text{ H}^+/\text{ATP}} = 2.5\)
P/O ≈ 1.5
FADH₂: 6 H⁺ pumped ÷ 4 H⁺/ATP = 1.5 ATP per FADH₂
\(\frac{6 \text{ H}^+}{4 \text{ H}^+/\text{ATP}} = 1.5\)
NADH Shuttle Systems
The inner mitochondrial membrane is impermeable to NADH. The reducing equivalents from cytoplasmic NADH (produced in glycolysis) must be transferred into the mitochondrial matrix via shuttle systems. The choice of shuttle determines the ATP yield from glycolytic NADH:
Malate-Aspartate Shuttle
Predominant in liver, kidney, and heart. Cytoplasmic NADH reduces OAA to malate (cytoplasmic malate DH), malate enters the matrix via the malate/α-KG antiporter, and matrix malate DH regenerates NADH inside the mitochondrion.
Yield: 2.5 ATP per cytoplasmic NADH
Electrons enter as mitochondrial NADH → Complex I
Glycerol-3-Phosphate Shuttle
Predominant in skeletal muscle and brain. Cytoplasmic NADH reduces DHAP to glycerol-3-phosphate (cytoplasmic G3P-DH). Mitochondrial G3P-DH (an FAD-linked enzyme on the outer face of the inner membrane) reoxidizes G3P and passes electrons to CoQ.
Yield: 1.5 ATP per cytoplasmic NADH
Electrons enter at CoQ level → bypass Complex I
Thermodynamic Efficiency
Efficiency Calculation:
Standard free energy of glucose oxidation:
Energy captured in ATP (assuming 32 ATP, \(\Delta G^{\circ\prime}_{\text{ATP}} = 30.5\) kJ/mol):
Standard-state efficiency:
Under actual cellular conditions, \(\Delta G_{\text{ATP}}\) is closer to −50 to −54 kJ/mol (due to non-standard concentrations), raising the effective efficiency to approximately 55–60%. The remaining energy is released as heat, which contributes to maintaining body temperature.
Reactive Oxygen Species (ROS)
The electron transport chain is not perfectly efficient. A small fraction of electrons (estimated at 0.1–2% of total electron flux) “leak” from the chain, particularly at Complexes I and III, and react prematurely with molecular oxygen to generate reactive oxygen species (ROS). While ROS serve important signaling functions at low concentrations, excessive ROS production causes oxidative damage to DNA, proteins, and lipids, contributing to aging and numerous diseases.
Major Reactive Oxygen Species
O₂•⁻
Superoxide anion
Primary ROS formed by one-electron reduction of O₂. Produced mainly at Complex I (FMN site and CoQ site) and Complex III (Qᵖ site during Q cycle).
H₂O₂
Hydrogen peroxide
Formed by dismutation of superoxide (spontaneous or via SOD). Relatively stable, can diffuse across membranes. Important signaling molecule at low concentrations.
OH•
Hydroxyl radical
Most damaging ROS. Formed from H₂O₂ via Fenton reaction: Fe²⁺ + H₂O₂ → Fe³⁺ + OH⁻ + OH•. Reacts indiscriminately with nearby biomolecules.
Antioxidant Defense Systems
Cells have evolved multi-layered antioxidant defenses to neutralize ROS and repair oxidative damage:
Enzymatic Defenses:
- • Superoxide dismutase (SOD): 2 O₂•⁻ + 2H⁺ → H₂O₂ + O₂. MnSOD (mitochondrial matrix), Cu/ZnSOD (cytoplasm and IMS)
- • Catalase: 2 H₂O₂ → 2 H₂O + O₂. Found primarily in peroxisomes
- • Glutathione peroxidase (GPx): H₂O₂ + 2 GSH → 2 H₂O + GSSG. Uses selenocysteine at active site; GPx4 specifically targets lipid hydroperoxides
- • Glutathione reductase: GSSG + NADPH → 2 GSH (regenerates reduced glutathione)
- • Thioredoxin/peroxiredoxin system: Reduces H₂O₂ and organic peroxides
Non-Enzymatic Antioxidants:
- • Glutathione (GSH): Most abundant intracellular thiol (~5 mM); tripeptide γ-Glu-Cys-Gly
- • Vitamin E (α-tocopherol): Lipid-soluble chain-breaking antioxidant; protects membrane lipids from peroxidation
- • Vitamin C (ascorbate): Water-soluble antioxidant; regenerates vitamin E
- • Coenzyme Q (ubiquinol): Acts as antioxidant in membranes in its reduced form
- • Uric acid: Scavenges hydroxyl radicals and singlet oxygen in plasma
Specific Sites of Electron Leak
Research has identified at least eleven distinct sites of superoxide and hydrogen peroxide production in mammalian mitochondria. However, the two quantitatively most important sites under physiological conditions are:
Complex I: FMN and CoQ Sites
Complex I produces superoxide from two distinct sites. The FMN site produces superoxide when the NADH/NAD⁺ ratio is high and the FMN becomes over-reduced. The CoQ-binding site (site Iᶜ) produces superoxide during reverse electron transport (RET), when a highly reduced CoQ pool forces electrons backward through Complex I. RET-derived ROS may be the dominant source during ischemia-reperfusion injury.
Complex III: Qᵖ Site
During the Q cycle, the unstable semiquinone radical at the Qᵖ site can donate its electron to O₂ rather than to the Rieske iron-sulfur protein. This is exacerbated when antimycin A blocks the Qᵢ site, trapping the semiquinone. Notably, Complex III releases superoxide to both sides of the inner membrane — into the matrix and the IMS — whereas Complex I releases superoxide exclusively into the matrix.
ROS, Aging, and Disease
The mitochondrial free radical theory of aging proposes that cumulative oxidative damage to mitochondrial DNA, proteins, and lipids contributes to the progressive decline in mitochondrial function associated with aging. Mitochondrial DNA is particularly vulnerable because it lacks protective histones, has limited repair mechanisms, and is located adjacent to the ETC (the primary source of ROS).
Excessive ROS production is implicated in numerous pathological conditions including neurodegenerative diseases (Parkinson’s — Complex I deficiency; Alzheimer’s), cardiovascular disease (ischemia-reperfusion injury), diabetes (glucotoxicity), cancer (DNA mutations), and inflammatory conditions.
Summary: The Complete Energy Balance
10 NADH → ~25 ATP
via oxidative phosphorylation (P/O = 2.5)
2 FADH₂ → ~3 ATP
via oxidative phosphorylation (P/O = 1.5)
4 ATP/GTP (SLP)
substrate-level phosphorylation
The 2 glycolytic NADH yield either 5 ATP (malate-aspartate shuttle) or 3 ATP (glycerol-3-phosphate shuttle), accounting for the 30–32 range.